Valganciclovir Powder, For Solution
Product Images NDC 72603-174

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 72603-174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Valganciclovircontainercarton (Valganciclovircontainercarton)

Label for Valganciclovir for Oral Solution 50 mg/mL, a powder for solution by NorthStar Rx LLC. The 100 mL package contains constituted oral solution with 50 mg valganciclovir free base per mL. The label includes preparation instructions, storage conditions, manufacturer information, and barcode.*

FDA Label Image

Valganciclovirformula (Valganciclovirformula)

An illustration showing two medical calculation formulas: the Mosteller Body Surface Area (BSA) formula and the Schwartz Creatinine Clearance formula, with variables including height, weight, serum creatinine, and a constant k.*

FDA Label Image

Valganciclovirinstrucfigure1 (Valganciclovirinstrucfigure1)

An instructional illustration showing components of a liquid medication package and oral dispenser. The medication bottle includes a child resistant cap, bottle adapter, and bottle. The oral dispenser features a plunger, barrel with measurement markings, and tip for dosing.*

FDA Label Image

Valganciclovirinstrucstep1 (Valganciclovirinstrucstep1)

Illustration showing a hand holding a bottle with instructions to shake well. The image depicts the proper handling of a liquid medication, likely indicating the need to mix the contents before use.*

FDA Label Image

Valganciclovirinstrucstep10a (Valganciclovirinstrucstep10a)

An instructional illustration showing a water faucet dripping water onto two syringes or measuring devices at an angle below the tap, suggesting a rinsing or mixing action.*

FDA Label Image

Valganciclovirinstrucstep10b (Valganciclovirinstrucstep10b)

An illustration of an oral syringe marked with measurement increments, designed for accurate dosing of medication in liquid form.*

FDA Label Image

Valganciclovirinstrucstep2 (Valganciclovirinstrucstep2)

An instructional diagram showing how to open a bottle by pushing down on the cap and turning it counterclockwise. The illustration focuses on demonstrating the opening mechanism of the bottle closure.*

FDA Label Image

Valganciclovirinstrucstep3 (Valganciclovirinstrucstep3)

An instructional diagram showing a dosage indicator on an oral dosing syringe for liquid medication. The syringe is graduated in milliliters (mL) with markings from 0 to 10 mL, labeled as "Dosage indicator (mL)." This illustration supports accurate measurement of oral doses for powdered solution medications like VALGANCICLOVIR 50 mg/mL.*

FDA Label Image

Valganciclovirinstrucstep4 (Valganciclovirinstrucstep4)

An instructional illustration showing a hand pressing down on a syringe plunger, demonstrating the correct technique to expel liquid or air from the syringe prior to administration.*

FDA Label Image

Valganciclovirinstrucstep5 (Valganciclovirinstrucstep5)

An instructional line drawing showing a hand using a bottle adapter to open a bottle, likely illustrating preparation steps for an oral solution dose, related to valganciclovir powder for solution.*

FDA Label Image

Valganciclovirinstrucstep6 (Valganciclovirinstrucstep6)

An instructional illustration depicting a person preparing an oral solution using a powder vial and a syringe. The image shows drawing liquid from the vial into the syringe, and then the syringe positioned for administration or transfer. The depiction is related to the preparation of a solution from a powder dosage form.*

FDA Label Image

Valganciclovirinstrucstep7 (Valganciclovirinstrucstep7)

An instructional illustration showing a hand holding a syringe above a small bottle, indicating the upward motion needed to draw liquid from the bottle into the syringe. This image supports oral administration preparation of a powder for solution dosage form.*

FDA Label Image

Valganciclovirinstrucstep8 (Valganciclovirinstrucstep8)

An instructional illustration showing a child receiving an oral medication using an oral syringe. A hand is administering liquid medication into the child's mouth, depicting the proper technique for oral dosing.*

FDA Label Image

Valganciclovirinstrucstep9 (Valganciclovirinstrucstep9)

A black and white illustration showing a close-up of the top part of a bottle with a child-resistant cap. Arrows indicate the direction to turn the cap for opening.*

FDA Label Image

Valganciclovirstructure (Valganciclovirstructure)

Chemical structure diagram of valganciclovir hydrochloride, the active ingredient shown in this image. The structure includes carbon, nitrogen, oxygen, hydrogen atoms, and a hydrochloride group (HCl).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.